 |
Subscribe / Renew |
 |
Contact Us |
| ► Subscribe to our Free Weekly Newsletter | |
Construction Bids
| home | Welcome, sign in or click here to subscribe. | login |
Business
 print  email to a friend  reprints add to mydjc |  |
August 4, 2020
Alpine Immune Sciences
In Seattle, Alpine Immune Sciences entered into a $60 million private stock placement led by Omega Funds with participation from Avidity Partners, EcoR1 Capital, Invus Public Equities and Samsara BioCapital. The money and existing cash are expected to fund development of the company's preclinical and clinical pipeline through 2024. Alpine is using immunotherapy to treat cancer, autoimmune/inflammatory and other diseases.